Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase II Study to Demonstrate the Safety and Efficacy of A4250 in Children With Cholestatic Pruritus

NCT02630875 is registered in ClinicalTrials.gov with Albireo as lead sponsor.

NCT NCT02630875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02630875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase II Study to Demonstrate the Safety and Efficacy of A4250 in Children With Cholestatic Pruritus
Lead sponsor
Albireo
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2015
Completion date
March 17, 2017
Enrollment
24 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cholestasis